Are you a journalist? Please sign up here for our press releases
Subscribe to our monthly newsletter:
Anticancer therapies
18.01.2024
Cancer, Immunology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs
A new kind of immunotherapy, based on crosstalk between different immune cells, could pave the way for innovative treatments of cancer and...
05.03.2023
Cancer, Personalized Medicine, Molecular and Cell Biology, Immunology, Disease, Drugs & Diagnostics, Diagnostic Techniques and Drugs
Sometimes anticancer antibodies press on the gas and the brakes at the same time. New research might help them accelerate better
08.02.2023
Weizmann Institute scientists have discovered how mutations in the BRCA genes, particularly prevalent among Ashkenazi Jews, lead to...
31.08.2022
Cancer, Viruses & Microorganisms, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Genetics
How tumors mutate their way out of a crisis – and become drug resistant in the process
23.03.2022
Natural antibodies found in tumors could point the way toward improved immunotherapy
28.11.2021
Structural Biology, Cancer, Molecular and Cell Biology, Disease, Drugs & Diagnostics, Yeda Technology Transfer, Diagnostic Techniques and Drugs
A particularly “sticky” molecule could lead to the development of an effective treatment for cancer
15.10.2021
Off-the-shelf therapies to be developed for entire groups of patients
16.09.2019
"We attain higher achievement, better results and the opportunity to advance our scientific careers"
17.07.2012
A molecule developed at the Institute can intercept potentially cancer-promoting messages before they reach the cell nucleus
12.06.2012
A small molecule developed at the Weizmann Institute prevents a cancer-causing message from entering the cell nucleus
